PRODUCTS

Analytical Instrument Documents

JEOL Resources

rss

Documentation in support of your JEOL product.

High Resolution LC/MS for Analysis of Minor Components in Complex Mixtures: Identification of Impurities and Degradation Products of a Novel Oligosaccharide Antibiotic

Conventional LC/MS and LC/MS/MS techniques have become an indispensable tool for analysis of minor components in complex mixtures. Such analyses include identification of isomers, drug metabolites, impurities, degradation products, reaction byproducts, individual components in combinatorial chemistry reaction mixtures, etc. However, when there is no prior structural information, such as structures of starting materials for a particular reaction, or a known drug substance that has generated certain metabolites, the complete structural identification becomes a difficult and time consuming task. Often, separation of the compound of interest and further analysis by complementary techniques, such as NMR, are required for full characterization. One way of overcoming these difficulties is the implementation of high resolution LC/MS using a magnetic sector mass spectrometer. Obtaining the elemental composition of parent and most abundant fragment ions provides significant help in the structural identification process. High resolution mass spectrometry has been routinely used for structural confirmation and identification, however, it has been limited to somewhat pure samples, for example, analysis of a typical drug metabolite mixture without the aid of liquid chromatography, has been impractical.

In this work, we report the identification of impurities and degradation products of Ziracin, a member of the Everninomicin class of antibiotics. Everninomicins belong to an important group of oligosaccharides, isolated from the fermentation broth, Micromonospora Carbonaceae, and are found to be highly active against Gram-positive bacteria including Methicillin resistant Staphylococci and Vancomycin resistant Enterococci. With the emergence of drug resistant strains of bacteria, a major effort is being directed towards the reevaluation of the efficacy of existing oligosaccarides and identification of new potential oligosaccaride antibiotics. Currently, the Everninomicin antibiotic Ziracin (SCH27889, Schering-Plough Corporation) is undergoing extensive trials to determine its clinical efficacy. Preliminary results suggest that Ziracin is safe and effective and if it proves successful in the large scale clinical trials, it could become a very important drug for treatment of human infections.

Attached Files
Showing 0 Comment


Comments are closed.

Other Resources

Image Gallery
  • View a selection of NMR and MS spectra
  • Walkup NMR
  • See how the Delta NMR software allows users to just "walk up" and start NMR experiments
  • Mass Spec Reference Data
  • View our page of useful molecular references for Mass Spec
  • Tutorials (Mass Spec)
  • Documents on the basics of mass spectrometry
  • Delta NMR software Tutorials
  • Videos on how to use the Delta NMR software
  • No-D NMR
  • Description of No-D NMR and how it can be used to eliminate the need for deuterated solvents
  • Non Uniform Sampling (NUS)
  • Description of how NUS is used to greatly reduce the time needed for running NMR experiments
  • NMR Basics
  • Overview of the Basics of NMR Theory
  • NMR Magnet Destruction
  • See our presentation of the slicing open of a JEOL Delta-GSX 270 MHz NMR Magnet
  • Media

    Corona - Glow Discharge (DART Ion Source)

    January 28, 2022
    2491
      JEOL USA, Inc.
      11 Dearborn Road
      Peabody, MA 01960
      © Copyright 2022 by JEOL USA, Inc.